Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Interleukin-1 receptor-associated kinase 1 [194-712] | ||
Ligand | BDBM348068 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Enzymatic Assay | ||
IC50 | <100±n/a nM | ||
Citation | Jorand-Lebrun, C; Jones, R; Won, AC; Nguyen, N; Johnson, TL; Deselm, LC; Panda, K Heteroaryl compounds as IRAK inhibitors and uses thereof US Patent US9790221 Publication Date 10/17/2017 | ||
More Info.: | Get all data from this article, Assay Method | ||
Interleukin-1 receptor-associated kinase 1 [194-712] | |||
Name: | Interleukin-1 receptor-associated kinase 1 [194-712] | ||
Synonyms: | IRAK | IRAK1 | IRAK1_HUMAN | Interleukin-1 receptor-associated kinase 1 (IRAK1) | ||
Type: | Enzyme Catalytic Domain | ||
Mol. Mass.: | 55943.99 | ||
Organism: | Homo sapiens (Human) | ||
Description: | aa 194-712 | ||
Residue: | 519 | ||
Sequence: |
| ||
BDBM348068 | |||
n/a | |||
Name | BDBM348068 | ||
Synonyms: | US9790221, Compound 276 | ||
Type | Small organic molecule | ||
Emp. Form. | C27H32N8O2S | ||
Mol. Mass. | 532.66 | ||
SMILES | Cn1cc(cn1)-c1cccc(c1)-c1ncc(-c2cnn(C)c2)c(N[C@H]2CC[C@@H](CC2)NS(=O)(=O)C2CC2)n1 |r,wU:27.33,wD:24.26,(1.09,5.84,;-.4,6.23,;-1.3,4.99,;-2.77,5.46,;-2.77,7,;-1.3,7.48,;-4.1,4.69,;-5.44,5.46,;-6.77,4.69,;-6.77,3.15,;-5.44,2.38,;-4.1,3.15,;-5.44,.84,;-6.77,.07,;-6.77,-1.47,;-5.44,-2.24,;-5.44,-3.78,;-6.68,-4.68,;-6.21,-6.15,;-4.67,-6.15,;-3.9,-7.48,;-4.19,-4.68,;-4.1,-1.47,;-2.77,-2.24,;-1.44,-1.47,;-.11,-2.24,;1.23,-1.47,;1.23,.07,;-.11,.84,;-1.44,.07,;2.56,.84,;3.9,.07,;3.13,-1.26,;4.67,-1.26,;5.23,.84,;6.77,.84,;6,2.18,;-4.1,.07,)| | ||
Structure |